Pineapple power: new supplement tested for IBS relief
NCT ID NCT07103772
First seen Jun 26, 2026 · Last updated Jun 26, 2026 · Updated 1 time
Summary
This study tests a nutraceutical supplement made from pineapple and natural extracts in 94 adults with irritable bowel syndrome (IBS). Participants take the supplement or a placebo daily for 14 days. Researchers track symptom changes using questionnaires and stool tests to see if the supplement helps reduce pain, bloating, and bowel issues.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- pineapple and natural extract supplement
- What this could lead to
- If it works, this could point toward a natural supplement to help manage IBS symptoms like pain and bloating.
- What could go wrong
- This is a small, early-stage trial with only 94 participants and a short 14-day treatment period. Results may not apply to everyone, and the supplement may not work better than placebo.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for IRRITABLE BOWEL SYNDROME are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Hospital Universitario Dr. Jose Eleuterio Gonzalez
Monterrey, Nuevo León, 64460, Mexico
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Could simple exercises calm gut inflammation and boost quality of life in IBS?
- Gut bacteria during infection may flag IBS risk
- Wheat sensitivity linked to fatty liver? a new study investigates
- Could a daily probiotic capsule tame irritable bowel syndrome?
- Can a simple diet switch calm IBS? a trial puts two popular eating plans to the test.
- Pregnancy and constipation drug: does prucalopride pose risks to unborn babies?